Permeability Barrier of Gram-Negative Cell Envelopes and Approaches to Bypass It

ACS Infectious Diseases

Volumn 1, Issue 11, 2016, Pages 512-522

  Zgurskaya, Helen I ^a   López, Cesar A ^b   Gnanakaran, S ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Gram negative resistance; multidrug efflux; outer membrane; permeability barrier

Indexed keywords

ANTIBIOTIC AGENT; LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN;

ARTICLE; BACTERIAL MEMBRANE; CELL MEMBRANE; CHEMICAL COMPOSITION; EFFUSION; GRAM NEGATIVE BACTERIUM; NONHUMAN; PATHOGENESIS; PERMEABILITY; PERMEABILITY BARRIER; PRIORITY JOURNAL;

EID: 84963979272     PISSN: None     EISSN: 23738227     Source Type: Journal    
DOI: 10.1021/acsinfecdis.5b00097     Document Type: Article

References (124)

1. Levy, S. B. and Marshall, B. (2004) Antibacterial resistance worldwide: causes, challenges and responses Nat. Med. 10, S122 10.1038/nm1145
2. Sievert, D. M. P., Ricks, P. P., Edwards, J. R. M. S., Schneider, A. M. P. H., Patel, J. P., Srinivasan, A. M. D., Kallen, A. M. D., Limbago, B. P., and Fridkin, S. M. D. (2013) For the National Healthcare Safety Network, T., and Participating, N. F. Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010 Infect. Control Hospital Epidemiol. 34, 1-14 10.1086/668770
3. Livermore, D. M. (2004) The need for new antibiotics Clin. Microbiol. Infect. 10 (Suppl. 4) 1-9 10.1111/j.1465-0691.2004.1004.x
4. Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., Kumarasamy, K., Livermore, D. M., Maya, J. J., Nordmann, P., Patel, J. B., Paterson, D. L., Pitout, J., Villegas, M. V., Wang, H., Woodford, N., and Quinn, J. P. (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases Lancet Infect. Dis. 13, 785-796 10.1016/S1473-3099(13)70190-7
5. Rice, L. B. (2012) Mechanisms of Resistance and Clinical Relevance of Resistance to β-Lactams, Glycopeptides, and Fluoroquinolones Mayo Clin. Proc. 87, 198-208 10.1016/j.mayocp.2011.12.003
6. Vasoo, S., Barreto, J. N., and Tosh, P. K. (2015) Emerging Issues in Gram-Negative Bacterial Resistance: An Update for the Practicing Clinician Mayo Clin. Proc. 90, 395-403 10.1016/j.mayocp.2014.12.002
7. Silver, L. L. (2011) Challenges of Antibacterial Discovery Clin. Microbiol. Rev. 24, 71-109 10.1128/CMR.00030-10
8. Lewis, K. (2012) Antibiotics: Recover the lost art of drug discovery Nature 485, 439-440 10.1038/485439a
9. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 46, 3-26 10.1016/S0169-409X(00)00129-0
10. Zgurskaya, H. I. (2009) Mechanisms of drug efflux and strategies to combat them. Preface Biochim. Biophys. Acta, Proteins Proteomics 1794, 723-724 10.1016/j.bbapap.2009.03.017
11. Nikaido, H. (2009) Multidrug Resistance in Bacteria Annu. Rev. Biochem. 78, 119-146 10.1146/annurev.biochem.78.082907.145923
12. Li, X.-Z., Plésiat, P., and Nikaido, H. (2015) The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria Clin. Microbiol. Rev. 28, 337-418 10.1128/CMR.00117-14
13. Delcour, A. H. (2009) Outer membrane permeability and antibiotic resistance Biochim. Biophys. Acta, Proteins Proteomics 1794, 808-816 10.1016/j.bbapap.2008.11.005
14. Nikaido, H. (2003) Molecular basis of bacterial outer membrane permeability revisited Microbiol. Mol. Biol. Rev.: MMBR 67, 593-656 10.1128/MMBR.67.4.593-656.2003
15. Lomovskaya, O., Zgurskaya, H. I., Totrov, M., and Watkins, W. J. (2007) Waltzing transporters and 'the dance macabre' between humans and bacteria Nat. Rev. Drug Discovery 6, 56-65 10.1038/nrd2200
16. Zgurskaya, H. I. (2009) Multicomponent drug efflux complexes: architecture and mechanism of assembly Future Microbiol. 4, 919-932 10.2217/fmb.09.62
17. Ziha-Zarifi, I., Llanes, C., Kohler, T., Pechere, J. C., and Plesiat, P. (1999) In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM Antimicrob. Agents Chemother. 43, 287-291
18. Swick, M. C., Morgan-Linnell, S. K., Carlson, K. M., and Zechiedrich, L. (2011) Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance Antimicrob. Agents Chemother. 55, 921-924 10.1128/AAC.00996-10
19. Padilla, E., Llobet, E., Doménech-Sánchez, A., Martínez-Martínez, L., Bengoechea, J. A., and Albertí, S. (2010) Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence Antimicrob. Agents Chemother. 54, 177-183 10.1128/AAC.00715-09
20. Chiu, C.-H., Lee, H.-Y., Tseng, L.-Y., Chen, C.-L., Chia, J.-H., Su, L.-H., and Liu, S.-Y. (2010) Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan Int. J. Antimicrob. Agents 35, 382-386 10.1016/j.ijantimicag.2009.12.009
21. Caroff, M. and Karibian, D. (2003) Structure of bacterial lipopolysaccharides Carbohydr. Res. 338, 2431-2447 10.1016/j.carres.2003.07.010
22. Kocincova, D. and Lam, J. S. (2011) Structural diversity of the core oligosaccharide domain of Pseudomonas aeruginosa lipopolysaccharide Biochemistry 76, 755-760 10.1134/S0006297911070054
23. Pier, G. B. (2007) Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity Int. J. Med. Microbiol. 297, 277-295 10.1016/j.ijmm.2007.03.012
24. Ernst, R. K., Moskowitz, S. M., Emerson, J. C., Kraig, G. M., Adams, K. N., Harvey, M. D., Ramsey, B., Speert, D. P., Burns, J. L., and Miller, S. I. (2007) Unique Lipid A Modifications in Pseudomonas aeruginosa Isolated from the Airways of Patients with Cystic Fibrosis J. Infect. Dis. 196, 1088-1092 10.1086/521367
25. Ernst, R. K., Hajjar, A. M., Tsai, J. H., Moskowitz, S. M., Wilson, C. B., and Miller, S. I. (2003) Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4 J. Endotoxin Res. 9, 395-400 10.1177/09680519030090060201
26. De Soyza, A., Silipo, A., Lanzetta, R., Govan, J. R., and Molinaro, A. (2008) Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides Innate Immun. 14, 127-144 10.1177/1753425908093984
27. Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., and Woodford, N. (2011) Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System Antimicrob. Agents Chemother. 55, 3370-3379 10.1128/AAC.00079-11
28. Plésiat, P. and Nikaido, H. (1992) Outer membranes of Gram-negative bacteria are permeable to steroid probes Mol. Microbiol. 6, 1323-1333 10.1111/j.1365-2958.1992.tb00853.x
29. Plesiat, P., Aires, J. R., Godard, C., and Köhler, T. (1997) Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa J. Bacteriol. 179, 7004-7010
30. Caroff, M. and Karibian, D. (2003) Structure of bacterial lipopolysaccharides Carbohydr. Res. 338, 2431-2447 10.1016/j.carres.2003.07.010
31. Knirel, Y. A., Bystrova, O. V., Kocharova, N. A., Zahringer, U., and Pier, G. B. (2006) Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa J. Endotoxin Res. 12, 324-336 10.1179/096805106X118906
32. Bystrova, O. V., Lindner, B., Moll, H., Kocharova, N. A., Knirel, Y. A., Zahringer, U., and Pier, G. B. (2004) Full structure of the lipopolysaccharide of Pseudomonas aeruginosa immunotype 5 Biochemistry (Moscow) 69, 170-175 10.1023/B:BIRY.0000018947.60328.8d
33. Isshiki, Y., Zähringer, U., and Kawahara, K. (2003) Structure of the core-oligosaccharide with a characteristic d -glycero-α- d -talo-oct-2-ulosylonate-(2→4)-3-deoxy- d -manno-oct-2-ulosonate [α-Ko-(2→4)-Kdo] disaccharide in the lipopolysaccharide from Burkholderia cepacia Carbohydr. Res. 338, 2659-2666 10.1016/j.carres.2003.07.005
34. Vinogradov, E. V., Müller-Loennies, S., Petersen, B. O., Meshkov, S., Thomas-Oates, J. E., Holst, O., and Brade, H. (1997) Structural Investigation of the Lipopolysaccharide from Acinetobacter haemolyticus Strain NCTC 10305 (ATCC 17906, DNA Group 4) Eur. J. Biochem. 247, 82-90 10.1111/j.1432-1033.1997.00082.x
35. Vinion-Dubiel, A. D. and Goldberg, J. B. (2003) Review: Lipopolysaccharide of Burkholderia cepacia complex J. Endotoxin Res. 9, 201-213 10.1177/09680519030090040101
36. Murata, T., Tseng, W., Guina, T., Miller, S. I., and Nikaido, H. (2007) PhoPQ-Mediated Regulation Produces a More Robust Permeability Barrier in the Outer Membrane of Salmonella enterica Serovar Typhimurium J. Bacteriol. 189, 7213-7222 10.1128/JB.00973-07
37. Raetz, C. R. H., Reynolds, C. M., Trent, M. S., and Bishop, R. E. (2007) Lipid A Modification Systems in Gram-Negative Bacteria Annu. Rev. Biochem. 76, 295-329 10.1146/annurev.biochem.76.010307.145803
38. Guo, L., Lim, K. B., Gunn, J. S., Bainbridge, B., Darveau, R. P., Hackett, M., and Miller, S. I. (1997) Regulation of Lipid A Modifications by Salmonella typhimurium Virulence Genes phoP-phoQ Science 276, 250-253 10.1126/science.276.5310.250
39. Olaitan, A. O., Morand, S., and Rolain, J.-M. (2014) Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria Front. Microbiol. 5, 643 10.3389/fmicb.2014.00643
40. Jo, S., Wu, E., Stuhlsatz, D., Klauda, J., MacKerell, A., Jr., Widmalm, G., and Im, W. (2015) Lipopolysaccharide membrane building and simulation. In Glycoinformatics (Lütteke, T. and Frank, M., Eds.), pp 391-406, Springer, New York.
41. Khalid, S., Berglund, N. A., Holdbrook, D. A., Leung, Y. M., and Parkin, J. (2015) The membranes of Gram-negative bacteria: progress in molecular modelling and simulation Biochem. Soc. Trans. 43, 162-167 10.1042/BST20140262
42. Dias, R. P., Li, L., Soares, T. A., and Alexov, E. (2014) Modeling the electrostatic potential of asymmetric lipopolysaccharide membranes: the MEMPOT algorithm implemented in DelPhi J. Comput. Chem. 35, 1418-1429 10.1002/jcc.23632
43. Nascimento, A., Pontes, F. J. S., Lins, R. D., and Soares, T. A. (2014) Hydration, ionic valence and cross-linking propensities of cations determine the stability of lipopolysaccharide (LPS) membranes Chem. Commun. 50, 231-233 10.1039/C3CC46918B
44. Nikaido, H. and Pages, J. M. (2012) Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria FEMS Microbiol Rev. 36, 340-363 10.1111/j.1574-6976.2011.00290.x
45. Pages, J. M., James, C. E., and Winterhalter, M. (2008) The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria Nat. Rev. Microbiol. 6, 893-903 10.1038/nrmicro1994
46. Pletzer, D., Braun, Y., Dubiley, S., Lafon, C., Köhler, T., Page, M. G. P., Mourez, M., Severinov, K., and Weingart, H. (2015) The Pseudomonas aeruginosa PA14 ABC Transporter NppA1A2BCD Is Required for Uptake of Peptidyl Nucleoside Antibiotics J. Bacteriol. 197, 2217-2228 10.1128/JB.00234-15
47. Krishnamoorthy, G., Tikhonova, E. B., Dhamdhere, G., and Zgurskaya, H. I. (2013) On the role of TolC in multidrug efflux: the function and assembly of AcrAB-TolC tolerate significant depletion of intracellular TolC protein Mol. Microbiol. 87, 982-997 10.1111/mmi.12143
48. Weeks, J. W., Celaya-Kolb, T., Pecora, S., and Misra, R. (2010) AcrA suppressor alterations reverse the drug hypersensitivity phenotype of a TolC mutant by inducing TolC aperture opening Mol. Microbiol. 75, 1468-1483 10.1111/j.1365-2958.2010.07068.x
49. Tamber, S. and Hancock, R. E. (2004) The outer membranes of Pseudomonads. In Pseudomonas (Ramos, J.-L., Ed.), pp 575-601, Kluwer Academic/Plenum Publishers, New York.
50. Sugawara, E. and Nikaido, H. (2012) OmpA Is the Principal Nonspecific Slow Porin of Acinetobacter baumannii J. Bacteriol. 194, 4089-4096 10.1128/JB.00435-12
51. Vila, J., Martí, S., and Sánchez-Céspedes, J. (2007) Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii J. Antimicrob. Chemother. 59, 1210-1215 10.1093/jac/dkl509
52. Sugawara, E., Nagano, K., and Nikaido, H. (2012) Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa FEBS J. 279, 910-918 10.1111/j.1742-4658.2012.08481.x
53. Sugawara, E., Nestorovich, E. M., Bezrukov, S. M., and Nikaido, H. (2006) Pseudomonas aeruginosa Porin OprF Exists in Two Different Conformations J. Biol. Chem. 281, 16220-16229 10.1074/jbc.M600680200
54. Sugawara, E. and Nikaido, H. (2012) OmpA is the principal nonspecific slow porin of Acinetobacter baumannii J. Bacteriol. 194, 4089-4096 10.1128/JB.00435-12
55. Eren, E., Parkin, J., Adelanwa, A., Cheneke, B., Movileanu, L., Khalid, S., and van den Berg, B. (2013) Toward Understanding the Outer Membrane Uptake of Small Molecules by Pseudomonas aeruginosa J. Biol. Chem. 288, 12042-12053 10.1074/jbc.M113.463570
56. Tamber, S., Ochs, M. M., and Hancock, R. E. W. (2006) Role of the Novel OprD Family of Porins in Nutrient Uptake in Pseudomonas aeruginosa J. Bacteriol. 188, 45-54 10.1128/JB.188.1.45-54.2006
57. van den Berg, B. (2012) Structural Basis for Outer Membrane Sugar Uptake in Pseudomonads J. Biol. Chem. 287, 41044-41052 10.1074/jbc.M112.408518
58. Zahn, M., D'Agostino, T., Eren, E., Baslé, A., Ceccarelli, M., and van den Berg, B. (2015) Small-Molecule Transport by CarO, an Abundant Eight-Stranded β-Barrel Outer Membrane Protein from Acinetobacter baumannii J. Mol. Biol. 427, 2329-2339 10.1016/j.jmb.2015.03.016
59. Mussi, M. A., Limansky, A. S., and Viale, A. M. (2005) Acquisition of Resistance to Carbapenems in Multidrug-Resistant Clinical Strains of Acinetobacter baumannii: Natural Insertional Inactivation of a Gene Encoding a Member of a Novel Family of β-Barrel Outer Membrane Proteins Antimicrob. Agents Chemother. 49, 1432-1440 10.1128/AAC.49.4.1432-1440.2005
60. Borneleit, P. and Kleber, H.-P. (1991) The outer membrane of Acinetobacter: structure-function relationships. In The Biology of Acinetobacter (Towner, K. J., Bergogne-Berezin, E., and Fewson, C. A., Eds.), pp 259-272, Plenum Press, New York.
61. Siritapetawee, J., Prinz, H., Krittanai, C., and Suginta, W. (2004) Expression and refolding of Omp38 from Burkholderia pseudomallei and Burkholderia thailandensis, and its function as a diffusion porin Biochem. J. 384, 609-617 10.1042/BJ20041102
62. Suginta, W., Mahendran, K. R., Chumjan, W., Hajjar, E., Schulte, A., Winterhalter, M., and Weingart, H. (2011) Molecular analysis of antimicrobial agent translocation through the membrane porin BpsOmp38 from an ultraresistant Burkholderia pseudomallei strain Biochim. Biophys. Acta, Biomembr. 1808, 1552-1559 10.1016/j.bbamem.2010.10.018
63. Siritapetawee, J., Prinz, H., Samosornsuk, W., Ashley, R. H., and Suginta, W. (2004) Functional reconstitution, gene isolation and topology modelling of porins from Burkholderia pseudomallei and Burkholderia thailandensis Biochem. J. 377, 579-587 10.1042/bj20031118
64. Tikhonova, E. B., Dastidar, V., Rybenkov, V. V., and Zgurskaya, H. I. (2009) Kinetic control of TolC recruitment by multidrug efflux complexes Proc. Natl. Acad. Sci. U. S. A. 106, 16416-16421 10.1073/pnas.0906601106
65. Tikhonova, E. B., Yamada, Y., and Zgurskaya, H. I. (2011) Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC Chem. Biol. 18, 454-463 10.1016/j.chembiol.2011.02.011
66. Tikhonova, E. B. and Zgurskaya, H. I. (2004) AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex J. Biol. Chem. 279, 32116-32124 10.1074/jbc.M402230200
67. Nikaido, H. and Zgurskaya, H. I. (1999) Antibiotic efflux mechanisms Curr. Opin. Infect. Dis. 12, 529-536 10.1097/00001432-199912000-00001
68. Phillips, J. L. and Gnanakaran, S. (2015) A data-driven approach to modeling the tripartite structure of multidrug resistance efflux pumps Proteins: Struct., Funct., Genet. 83, 46-65 10.1002/prot.24632
69. Zgurskaya, H. I. and Nikaido, H. (1999) Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 96, 7190-7195 10.1073/pnas.96.13.7190
70. Yu, E. W., McDermott, G., Zgurskaya, H. I., Nikaido, H., and Koshland, D. E., Jr. (2003) Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump Science 300, 976-980 10.1126/science.1083137
71. Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., and Yamaguchi, A. (2006) Crystal structures of a multidrug transporter reveal a functionally rotating mechanism Nature 443, 173-179 10.1038/nature05076
72. Vargiu, A. V. and Nikaido, H. (2012) Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations Proc. Natl. Acad. Sci. U. S. A. 109, 20637-20642 10.1073/pnas.1218348109
73. Nakashima, R., Sakurai, K., Yamasaki, S., Nishino, K., and Yamaguchi, A. (2011) Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket Nature 480, 565-569 10.1038/nature10641
74. Nagano, K. and Nikaido, H. (2009) Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 106, 5854-5858 10.1073/pnas.0901695106
75. Poole, K. and Srikumar, R. (2001) Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance Curr. Top. Med. Chem. 1, 59-71 10.2174/1568026013395605
76. Pumbwe, L. and Piddock, L. J. (2000) Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa Antimicrob. Agents Chemother. 44, 2861-2864 10.1128/AAC.44.10.2861-2864.2000
77. Poole, K. (2004) Efflux-mediated multiresistance in Gram-negative bacteria Clin. Microbiol. Infect. 10, 12-26 10.1111/j.1469-0691.2004.00763.x
78. Aendekerk, S., Diggle, S. P., Song, Z., Hoiby, N., Cornelis, P., Williams, P., and Camara, M. (2005) The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication Microbiology 151, 1113-1125 10.1099/mic.0.27631-0
79. Hirakata, Y., Srikumar, R., Poole, K., Gotoh, N., Suematsu, T., Kohno, S., Kamihira, S., Hancock, R. E., and Speert, D. P. (2002) Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa J. Exp. Med. 196, 109-118 10.1084/jem.20020005
80. Podnecky, N. L., Rhodes, K. A., and Schweizer, H. P. (2015) Efflux Pump-mediated Drug Resistance in Burkholderia Front. Microbiol. 6, 305 10.3389/fmicb.2015.00305
81. Buroni, S., Matthijs, N., Spadaro, F., Van Acker, H., Scoffone, V. C., Pasca, M. R., Riccardi, G., and Coenye, T. (2014) Differential Roles of RND Efflux Pumps in Antimicrobial Drug Resistance of Sessile and Planktonic Burkholderia cenocepacia Cells Antimicrob. Agents Chemother. 58, 7424-7429 10.1128/AAC.03800-14
82. Coyne, S., Courvalin, P., and Périchon, B. (2011) Efflux-Mediated Antibiotic Resistance in Acinetobacter spp Antimicrob. Agents Chemother. 55, 947-953 10.1128/AAC.01388-10
83. Yoon, E.-J., Nait Chabane, Y., Goussard, S., Snesrud, E., Courvalin, P., Dé, E., and Grillot-Courvalin, C. (2015) Contribution of Resistance-Nodulation-Cell Division Efflux Systems to Antibiotic Resistance and Biofilm Formation in Acinetobacter baumannii mBio 6, e00309-15 10.1128/mBio.00309-15
84. Sulavik, M. C., Houseweart, C., Cramer, C., Jiwani, N., Murgolo, N., Greene, J., DiDomenico, B., Shaw, K. J., Miller, G. H., Hare, R., and Shimer, G. (2001) Antibiotic Susceptibility Profiles of Escherichia coli Strains Lacking Multidrug Efflux Pump Genes Antimicrob. Agents Chemother. 45, 1126-1136 10.1128/AAC.45.4.1126-1136.2001
85. Tal, N. and Schuldiner, S. (2009) A coordinated network of transporters with overlapping specificities provides a robust survival strategy Proc. Natl. Acad. Sci. U. S. A. 106, 9051-9056 10.1073/pnas.0902400106
86. Lee, A., Mao, W., Warren, M. S., Mistry, A., Hoshino, K., Okumura, R., Ishida, H., and Lomovskaya, O. (2000) Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance J. Bacteriol. 182, 3142-3150 10.1128/JB.182.11.3142-3150.2000
87. Zgurskaya, H. I. and Nikaido, H. (2002) Mechanistic parallels in bacterial and human multidrug efflux transporters Curr. Protein Pept. Sci. 3, 531-540 10.2174/1389203023380512
88. Fluman, N. and Bibi, E. (2009) Bacterial multidrug transport through the lens of the major facilitator superfamily Biochim. Biophys. Acta, Proteins Proteomics 1794, 738-747 10.1016/j.bbapap.2008.11.020
89. Schuldiner, S. (2009) EmrE, a model for studying evolution and mechanism of ion-coupled transporters Biochim. Biophys. Acta, Proteins Proteomics 1794, 748-762 10.1016/j.bbapap.2008.12.018
90. Kuroda, T. and Tsuchiya, T. (2009) Multidrug efflux transporters in the MATE family Biochim. Biophys. Acta, Proteins Proteomics 1794, 763-768 10.1016/j.bbapap.2008.11.012
91. Walsh, C. T. and Wencewicz, T. A. (2014) Prospects for new antibiotics: a molecule-centered perspective J. Antibiot. 67, 7-22 10.1038/ja.2013.49
92. Vaara, M. (2010) Polymyxins and their novel derivatives Curr. Opin. Microbiol. 13, 574-581 10.1016/j.mib.2010.09.002
93. Velkov, T., Roberts, K. D., Nation, R. L., Wang, J., Thompson, P. E., and Li, J. (2014) Teaching 'Old' Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative 'Superbugs' ACS Chem. Biol. 9, 1172-1177 10.1021/cb500080r
94. Pucci, M. J. and Bush, K. (2013) Investigational Antimicrobial Agents of 2013 Clin. Microbiol. Rev. 26, 792-821 10.1128/CMR.00033-13
95. Isabella, V. M., Campbell, A. J., Manchester, J., Sylvester, M., Nayar, A. S., Ferguson, K. E., Tommasi, R., and Miller, A. A. (2015) Toward the Rational Design of Carbapenem Uptake in Pseudomonas aeruginosa Chem. Biol. 22, 535-547 10.1016/j.chembiol.2015.03.018
96. Schalk, I. J., Mislin, G. L. A., and Brillet, K. (2012) Chapter 2. Structure, function and binding selectivity and stereoselectivity of siderophore-iron outer membrane transporters. In Current Topics in Membranes (José, M. A. and Svetlana, L., Eds.), pp 37-66, Academic Press, San Diego, CA, USA.
97. Braun, V. and Hantke, K. (2011) Recent insights into iron import by bacteria Curr. Opin. Chem. Biol. 15, 328-334 10.1016/j.cbpa.2011.01.005
98. Cunrath, O., Geoffroy, V. A., and Schalk, I. J. (2015) Metallome of Pseudomonas aeruginosa: a role for siderophores Environ. Microbiol. n/a-n/a 10.1111/1462-2920.12971
99. Page, M. G. P. (2013) Siderophore conjugates Ann. N. Y. Acad. Sci. 1277, 115-126 10.1111/nyas.12024
100. Page, M. G. P., Dantier, C., and Desarbre, E. (2010) In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli Antimicrob. Agents Chemother. 54, 2291-2302 10.1128/AAC.01525-09
101. Chen, R. H., Buko, A. M., Whittern, D. N., and McAlpine, J. B. (1989) Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation J. Antibiot. 42, 512-520 10.7164/antibiotics.42.512
102. Fernandes, P. B., Swanson, R. N., Hardy, D. J., Hanson, C. W., Coen, L., Rasmussen, R. R., and Chen, R. H. (1989) Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. III. Microbiologic profile J. Antibiot. 42, 521-526 10.7164/antibiotics.42.521
103. Karwowski, J. P., Jackson, M., Theriault, R. J., Chen, R. H., Barlow, G. J., and Maus, M. L. (1989) Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. I. Taxonomy of the producing organism and fermentation J. Antibiot. 42, 506-511 10.7164/antibiotics.42.506
104. Mistry, A., Warren, M. S., Cusick, J. K., Karkhoff-Schweizer, R. R., Lomovskaya, O., and Schweizer, H. P. (2013) High-Level Pacidamycin Resistance in Pseudomonas aeruginosa Is Mediated by an Opp Oligopeptide Permease Encoded by the opp-fabI Operon Antimicrob. Agents Chemother. 57, 5565-5571 10.1128/AAC.01198-13
105. O'Shea, R. and Moser, H. E. (2008) Physicochemical properties of antibacterial compounds: implications for drug discovery J. Med. Chem. 51, 2871-2878 10.1021/jm700967e
106. Burns, A. R., Wallace, I. M., Wildenhain, J., Tyers, M., Giaever, G., Bader, G. D., Nislow, C., Cutler, S. R., and Roy, P. J. (2010) A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans Nat. Chem. Biol. 6, 549-557 10.1038/nchembio.380
107. Davis, T. D., Gerry, C. J., and Tan, D. S. (2014) General Platform for Systematic Quantitative Evaluation of Small-Molecule Permeability in Bacteria ACS Chem. Biol. 9, 2535-2544 10.1021/cb5003015
108. Zhou, Y., Joubran, C., Miller-Vedam, L., Isabella, V., Nayar, A., Tentarelli, S., and Miller, A. (2015) Thinking Outside the "Bug": A Unique Assay To Measure Intracellular Drug Penetration in Gram-Negative Bacteria Anal. Chem. 87, 3579-3584 10.1021/ac504880r
109. Manchester, J. I., Buurman, E. T., Bisacchi, G. S., and McLaughlin, R. E. (2012) Molecular determinants of AcrB-mediated bacterial efflux implications for drug discovery J. Med. Chem. 55, 2532-2537 10.1021/jm201275d
110. Parkin, J., Chavent, M., and Khalid, S. (2015) Molecular Simulations of Gram-Negative Bacterial Membranes: A Vignette of Some Recent Successes Biophys. J. 109, 461-468 10.1016/j.bpj.2015.06.050
111. Berglund, N. A., Piggot, T. J., Jefferies, D., Sessions, R. B., Bond, P. J., and Khalid, S. (2015) Interaction of the antimicrobial peptide polymyxin B1 with both membranes of E. coli: a molecular dynamics study PLoS Comput. Biol. 11, e1004180 10.1371/journal.pcbi.1004180
112. Bohnert, J. A. and Kern, W. V. (2005) Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps Antimicrob. Agents Chemother. 49, 849-852 10.1128/AAC.49.2.849-852.2005
113. Renau, T. E., Leger, R., Filonova, L., Flamme, E. M., Wang, M., Yen, R., Madsen, D., Griffith, D., Chamberland, S., Dudley, M. N., Lee, V. J., Lomovskaya, O., Watkins, W. J., Ohta, T., Nakayama, K., and Ishida, Y. (2003) Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa Bioorg. Med. Chem. Lett. 13, 2755-2758 10.1016/S0960-894X(03)00556-0
114. Watkins, W. J., Landaverry, Y., Leger, R., Litman, R., Renau, T. E., Williams, N., Yen, R., Zhang, J. Z., Chamberland, S., Madsen, D., Griffith, D., Tembe, V., Huie, K., and Dudley, M. N. (2003) The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors Bioorg. Med. Chem. Lett. 13, 4241-4244 10.1016/j.bmcl.2003.07.030
115. Opperman, T. J. and Nguyen, S. T. (2015) Recent advances toward a molecular mechanism of efflux pump inhibition Front. Microbiol. 6, e00421 10.3389/fmicb.2015.
116. Lomovskaya, O., Zgurskaya, H. I., and Bostian, K. A. (2008) Bacterial multidrug transporters: molecular and clinical aspects. In Transporters as Drug Carriers (Ecker, G. F. and Chiba, P., Eds.), Wiley and Sons, Hoboken, NJ, USA.
117. Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., Leger, R., Hecker, S., Watkins, W., Hoshino, K., Ishida, H., and Lee, V. J. (2001) Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy Antimicrob. Agents Chemother. 45, 105-116 10.1128/AAC.45.1.105-116.2001
118. Watkins, W. J., Chong, L., Cho, A., Hilgenkamp, R., Ludwikow, M., Garizi, N., Iqbal, N., Barnard, J., Singh, R., Madsen, D., Lolans, K., Lomovskaya, O., Oza, U., Kumaraswamy, P., Blecken, A., Bai, S., Loury, D. J., Griffith, D. C., and Dudley, M. N. (2007) Quinazolinone fungal efflux pump inhibitors. Part 3: (N-methyl)piperazine variants and pharmacokinetic optimization Bioorg. Med. Chem. Lett. 17, 2802-2806 10.1016/j.bmcl.2007.02.047
119. Thorarensen, A., Presley-Bodnar, A. L., Marotti, K. R., Boyle, T. P., Heckaman, C. L., Bohanon, M. J., Tomich, P. K., Zurenko, G. E., Sweeney, M. T., and Yagi, B. H. (2001) 3-Arylpiperidines as potentiators of existing antibacterial agents Bioorg. Med. Chem. Lett. 11, 1903-1906 10.1016/S0960-894X(01)00330-4
120. Opperman, T. J., Kwasny, S. M., Kim, H.-S., Nguyen, S. T., Houseweart, C., D'Souza, S., Walker, G. C., Peet, N. P., Nikaido, H., and Bowlin, T. L. (2014) Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli Antimicrob. Agents Chemother. 58, 722-733 10.1128/AAC.01866-13
121. Nakayama, K., Ishida, Y., Ohtsuka, M., Kawato, H., Yoshida, K.-i., Yokomizo, Y., Hosono, S., Ohta, T., Hoshino, K., Ishida, H., Yoshida, K., Renau, T. E., Léger, R., Zhang, J. Z., Lee, V. J., and Watkins, W. J. (2003) MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization Bioorg. Med. Chem. Lett. 13, 4201-4204 10.1016/j.bmcl.2003.07.024
122. Nakashima, R., Sakurai, K., Yamasaki, S., Hayashi, K., Nagata, C., Hoshino, K., Onodera, Y., Nishino, K., and Yamaguchi, A. (2013) Structural basis for the inhibition of bacterial multidrug exporters Nature 500, 102-106 10.1038/nature12300
123. Lomovskaya, O. et al. 1999, Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 43, 1340-1346
124. Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene-Agyei, T., Venter, H., Chiu, W., and Luisi, B. F. (2014) Structure of the AcrAB-TolC multidrug efflux pump Nature 509, 512-515 10.1038/nature13205